Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

NCT00004497 is registered in ClinicalTrials.gov with United Therapeutics as lead sponsor.

NCT NCT00004497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
Lead sponsor
United Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1998
Completion date
September 30, 2000
Enrollment
Not reported
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension